Walgreens Globals

Fingomod 0.5 mg CapsulesBrand Names: Fingomod, Gilenya (original brand name: Gilenya)Composition: Fingolimod 0.5 mgStrength: 0.5 mg per capsuleManufacturer: Various manufacturers, including Natco Pharma and other pharmaceutical companies.Packaging: Typically available in blister packs containing 10 capsules.Treatment: Fingomod 0.5 mg Capsules are used for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of relapses and delay the progression of disability.Product Description:Fingomod 0.5 mg Capsule contains Fingolimod, an immunomodulating drug that works by retaining certain white blood cells (lymphocytes) in the lymph nodes, preventing them from migrating to the central nervous system (CNS) where they could cause inflammation and damage to nerve cells. This mechanism helps in reducing the frequency of relapses in patients with multiple sclerosis and slows the progression of the disease.Common indications for Fingomod 0.5 mg Capsules include:Relapsing-Remitting Multiple Sclerosis (RRMS): To reduce the frequency of clinical exacerbations and delay the accumulation of physical disability.Secondary Progressive Multiple Sclerosis (SPMS): In some cases, to manage active disease with relapses.First-line Treatment: In some countries, for patients who have not responded adequately to other MS therapies or for those with aggressive disease onset.Dosage and Administration:For Adults: The typical dose is 0.5 mg taken once daily, with or without food.Administration: Fingomod capsules should be swallowed whole with water. It is important not to crush, chew, or open the capsules. Patients are usually monitored for at least 6 hours after the first dose to check for any cardiac effects, such as bradycardia (slow heart rate).Patients taking Fingomod should be under regular supervision by a healthcare provider due to the potential for serious side effects. Regular monitoring of blood pressure, liver function, and eye health is recommended during treatment.Common side effects of Fingomod 0.5 mg Capsules may include:HeadacheBack painDiarrheaCoughElevated liver enzymesBradycardia (especially after the first dose)Infections, due to the immunosuppressive effectSerious side effects can include macular edema, severe infections, and liver injury. If any severe or unusual symptoms occur, it is essential to seek medical attention immediately.Packaging:Fingomod 0.5 mg Capsules are typically packaged in blister packs containing 10 capsules, with clear labeling for dosage and safety information.Fingomod 0.5 mg Capsules (Fingolimod) are an important treatment option for managing relapsing forms of multiple sclerosis. Adherence to the prescribed dosage, regular monitoring by a healthcare provider, and awareness of potential side effects are crucial for ensuring the effectiveness and safety of the treatment.

Product Name: Mirel 18mg Powder for Injection

Brand Name: Mirel, Retavase, Rapilysin

Composition: Reteplase (18mg)

Manufacturer/Marketer: Reliance Life Sciences

Packaging: To be provided (specify packaging details if available)

Treatment: Acute myocardial infarction (heart attack)

Product Description: Mirel 18mg Powder for Injection contains Reteplase, a thrombolytic agent used for the emergency treatment of acute myocardial infarction (heart attack). It works by dissolving blood clots in the arteries, restoring blood flow to the heart and reducing the risk of severe complications. This medication is administered under medical supervision in a hospital setting

Product Name: Cravorine 20

Brand Name: Cravorine, Tinnex, Spasmarex

Composition: Caroverine (20mg)

Manufacturer/Marketer: Steris Healthcare

Packaging: To be provided (specify packaging details if available)

Treatment: Tinnitus, muscle spasms, gastrointestinal motility disorders

Product Description: Cravorine 20 contains Caroverine, a spasmolytic and neuroprotective agent. It is primarily used to manage tinnitus (ringing in the ears) and treat muscle spasms or gastrointestinal motility disorders. Caroverine works by relaxing smooth muscles and improving blood flow to affected areas, reducing symptoms effectively

Product Name: Ocrevus 300mg Injection

Brand Name: Ocrevus

Composition: Ocrelizumab (300mg)

Manufacturer/Marketer: Roche Diagnostics India Pvt. Ltd.

Packaging: To be provided (specify packaging details if available)

Treatment: Multiple sclerosis (Relapsing and Primary Progressive MS)

Product Description: Ocrevus 300mg Injection contains Ocrelizumab, a monoclonal antibody used to treat multiple sclerosis (MS). It works by targeting and reducing certain immune cells (B-cells) that contribute to nerve damage, slowing disease progression and reducing relapses in relapsing and primary progressive MS

Product Name: ANVIMO Tablet

Brand Name: ANVIMO, Prevymis, Letem

Composition: Letermovir (240mg/480mg)

Manufacturer/Marketer: Zydus Healthcare

Packaging: To be provided (specify packaging details if available)

Treatment: Cytomegalovirus (CMV) infection prophylaxis in transplant patients

Product Description: ANVIMO Tablet contains Letermovir, an antiviral medication used for the prevention of cytomegalovirus (CMV) infection in adult patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). It works by inhibiting CMV replication, reducing the risk of CMV-related complications in immunocompromised individuals

Product Name: Meflotas 250mg TabletBrand Name: Meflotas, Lariam, MephaquinComposition: Mefloquine (250mg)Manufacturer/Marketer: Intas Pharmaceuticals LtdPackaging: To be provided (specify packaging details if available)Treatment: Malaria prevention and treatmentProduct Description: Meflotas 250mg Tablet contains Mefloquine, an antimalarial medication used for the prevention and treatment of malaria. It works by interfering with the growth and replication of the malaria parasite in the red blood cells, helping to control and eliminate the infection

Product Name: Novo Eight 500iu InjectionBrand Names: NovoEight, Kogenate FS, AdvateComposition: Recombinant Human Coagulation Factor VIII (Turoctocog Alfa) - 500 IUManufacturer/Marketer: NOVO NORDISK INDIA PVT LTD.Packaging: To be provided (specify packaging details if available)Treatment: Hemophilia AProduct Description: Novo Eight 500iu Injection contains Turoctocog Alfa, a recombinant form of human coagulation factor VIII. It is used to manage and prevent bleeding episodes in individuals with Hemophilia A, a condition where blood clotting is impaired. This medication helps replace the missing or defective factor VIII, promoting proper blood coagulation